I. Jalšenjak, Gj. Deželić, J.J. Petres, Ž. Telišman, Preparation of monodisperse latices by g-ray polimerization and their electron-microscopis and electrophoretic characterization, Croat. Chem. Acta 46 (1974) 157.
I. Jalšenjak, C.F. Nicolaidou, J.R. Nixon, The in vitro dissolution of phenobarbitone sodium from ethyl cellulose microcapsules, J. Pharm. Pharmacol. 28 (1976) 912.
I. Jalšenjak, V. Vidmar, I. Štivić, In vivo and in vitro evaluation of ethyl cellulose microcapsules with sodium phenobarbitone, Acta Pharm. Jugosl. 27 (1977) 191.
I. Jalšenjak, C.F. Nicolaidou, J.R. Nixon, Dissolution from tablets prepared using ethyl cellulose microcapsules, J. Pharm. Pharmacol. 29 (1977) 169.
I. Jalšenjak, I. Štivić, J.J. Petres, Viscosimetric determination of latex coagulation, Croat. Chem. Acta 50 (1978) 141.
J.R. Nixon, I. Jalšenjak, C.F. Nicolaidou, M. Harris, Release of drugs from suspended and tabletted microcapsules, Drug Develop. Indust. Pharm. 4 (1978) 117.
R. Senjković, I. Jalšenjak, Study of dissolution rate methods in vitro, Acta Pharm. Jugosl. 28 (1978) 171.
I. Jalšenjak, J.R. Nixon, R. Senjković, I. Štivić, Sustain-release dosage forms of microencapsulated isoniazid, J. Pharm. Pharmacol. 32 (1980) 678.
F. Colnago, I. Štivić, I. Jalšenjak, Drug release and rheological characteristics of oleaginous ointments, Acta Pharm. Technol. 26 (1980) 61.
I. Jalšenjak, I. Štivić, Rheological study of particle interaction in a concentrated polymer dispersion, Polymer 22 (1981) 847.
R. Senjković, I. Jalšenjak, Apparent diffusion coefficient of sodium phenobarbitone in ethylcellulose microcapsules: Effects of capsule size, J. Pharm. Pharmacol. 33 (1981) 279.
I. Jalšenjak, T. Kondo, Effect of capsule size on permeability of gelatin-acacia microcapsules toward sodium chloride, J. Pharm. Sci. 70 (1981) 456.
R. Senjković, I. Jalšenjak, Surface topography of microcapsules and the drug release, J. Pharm. Pharmacol. 33 (1981) 665.
S. Pepeljnjak, I. Jalšenjak, D. Maysinger, Influence of microencapsulated propolis extract on bacillus subtilis strain IP-5832, Acta Pharm. Jugosl. 31 (1981) 27.
R. Senjković, I. Jalšenjak, Effect of capsule size and membrane density on permeability of ethyl cellulose microcapsules, Pharm. Acta Helv. 57 (1982) 16.
S. Pepeljnjak, I. Jalšenjak, D. Maysinger, Growth inhibition of Bacillus subtilis and composition of various propolis extracts, Pharmazie 37 (1982) 864.
V. Vidmar, I. Jalšenjak, Kinetics and mechanism of release of water-soluble drug from microcapsules, Acta Pharm. Technol. 28 (1982) 78.
V. Vidmar, I. Jalšenjak, T. Kondo, Volume of water-filled pores in the ethyl cellulose membrane and the permeability of microcapsules, J. Pharm. Pharmacol. 34 (1982) 411.
S. Pepeljnjak, I. Jalšenjak, D. Maysinger, Inhibition of growth and biosynthesis of ochratoxine A in Aspergillus sulphureus NRRL 4077 by propolis extract, Pharmazie 37 (1982) 439.
S. Pepeljnjak, D. Maysinger, I. Jalšenjak, Effect of propolis extracts on some fungi. Sci. Pharm. 50 (1982) 165.
V. Vidmar, I. Jalšenjak, Influence of drug partition coefficient and pH value of sink solution on permeation from porous thick-walled ethyl cellulose microcapsules, J. Pharm. Pharmacol. 35 (1983) 482.
D. Maysinger, I. Jalšenjak, In situ absorption and in vitro release of microencapsulated cimetidine, Int. J. Pharm. 17 (1983) 129.
V. Vidmar, A. Smolčić-Bubalo, I. Jalšenjak, Poly(lactic acid) microencapsulated oxytetracycline: In vitro and in vivo evaluation, J. Microencapsulation 1 (1984) 131.
S. Pepeljnjak, I. Jalšenjak, Usage of propolis extract for preserving food against microbiological contamination, Microbiologie-Aliments-Nutrition 2 (1984) 301.
R. Senjković, I. Jalšenjak, Influence of the atomization time on the properties of ethylcellulose microcapsules of isoniazid prepared by a fluidized bed, J. Microencapsulation 1 (1984) 241.
S. Pepeljnjak I. Jalšenjak, D. Maysinger, Flavonoid content in propolis extracts and growth inhibition of Bacillus subtilis, Pharmazie 40 (1985) 122.
V. Vidmar, S. Pepeljnjak, I. Jalšenjak, The in vivo evaluation of poly(lactic acid) microcapsules of pilocarpine hydrochloride, J. Microencapsulation 2 (1985) 289.
V. Jalšenjak, S. Stolnik, D. Maysinger, I. Jalšenjak, Development of biodegradable microcapsules for controlled drug release into the brain, Acta Pharm. Jugoslav. 38 (1988) 297.
D. Maysinger, V. Jalšenjak, S. Stolnik L. Garofalo, A.C. Cuello, I. Jalšenjak, Microencapsulated monosialoganglioside GM1: Physical properties and in vivo effects, J. Microencapsulation 6 (1989) 35.
D. Maysinger, L. Garofalo, I. Jalšenjak, A.C. Cuello, Effects of microencapsulated monosialoganglioside GM1 on cholinergic neurons, Brain Research 496 (1989) 165.
D. Juretić, I. Čepelak, V. Jalšenjak, T. Žanić, K. Lipovac, I. Jalšenjak, Effect of microencapsulated acetylsalicylic acid on glycosylation of human serum proteins in vitro, Int. J. Pharm. 61 (1990) 219.
D. Maysinger, B. Zorc, I. Butula, I. Jalšenjak, Preparation and in vivo effect of microencapsulated cholinotoxin, Int. J. Pharm. 63 (1990) 149.
N. Škalko, M. Čajkovac, I. Jalšenjak, Liposomes with clindamycin hydrochloride in therapy of Acne vulgaris, Int. J. Pharm. 85 (1992) 97.
D. Maysinger, I. Jalšenjak, A.C. Cuello, Microencapsulated nerve growth factor: Effects on the forebrain neurons following devascularizing cortical lesions, Neurosci. Let. 140 (1992) 71.
I. Jalšenjak, In vitro release from microcapsules and microspheres, Chapter XI In: M. Donbrow (Ed.) Microcapsules in Medicine and Pharmacy, CRC Press, Boca Raton 1992.
D. Maysinger, S. Stolnik, V. Jalšenjak, I. Jalšenjak, Release of L-dopa from microspheres into the rat brain: in vitro and in vivo characterization by microdialysis, Chapter XXIII In: T.L. Whateley and A. J. Baillie (Eds.) Microencapsulation of Drugs, Gordon and Breach, Harwood 1992.
J. Filipović-Grčić, I. Jalšenjak, HSA microspheres of barbiturates: Effect of drug partition coefficient on preparation and drug release, J. Pharm. Pharmacol. 45 (1993) 394.
B. Zorc, M. Ljubić, S. Antolić, J. Filipović-Grčić, D. Maysinger, T. Alebić-Kolbah, I. Jalšenjak, Polymeric prodrugs of L-dopa and a-methyldopa, Int. J. Pharm. 99 (1993) 135.
D. Maysinger, P. Piccardo, P. Liberini, I. Jalšenjak, A.C. Cuello, Encapsulated genetically engineered fibroblasts: Release of nerve growth factor and effets in vivo on recovery of cholinergic markers after devascularizing cortical lesions, Neurochem. Internat. 24 (1994) 495.
J. Filipović-Grčić, D. Maysinger, B. Zorc, I. Jalšenjak, Macromolecular prodrugs. IV. Alginate-chitosan microspheres of PHEA-L-dopa adduct, Int. J. Pharm. 116 (1995) 39.
J. Filipović-Grčić, D. Maysinger, I. Jalšenjak, Microparticles with neuroactive agents, J. Microencapsulation 12 (1995) 343.
T. Tejima, I. Jalšenjak, T. Kondo, Permeability to solutes of polyamide capsules with different chemical compositions, J. Microencapsulation 13 (1996) 377.
J. Filipović-Grčić, M. Bećirević-Laćan, N. Škalko, I. Jalšenjak, Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes, Int. J. Pharm. 135 (1996) 183.
N. Škalko, J. Filipović-Grčić, M. Bećirević-Laćan, I. Jalšenjak, Nifedipine and nifedipine-cyclodextrin complexes in liposomes and microspheres, Acta Pharm. 46 (1996) 159.
N. Škalko, M. Brandl, M. Bećirević-Laćan, J. Filipović-Grčić, I. Jalšenjak, Liposomes with nifedipine and nifedipine-cyclodextrin complex: Calorimetrical and plasma stability comparison, Europ. J. Pharm. Sci. 4 (1996) 359.
M. Bećirević-Laćan, J. Filipović-Grčić, N. Škalko, I. Jalšenjak, Dissolution characteristics of nifedipine complexes with b-cyclodextrins, Drug Develop. Ind. Pharm. 22 (1996) 1231.
N. Škalko, M. Čajkovac, I. Jalšenjak, Liposomes with metronidazole for topical use: The choice of preparation method and vehicle, J. Liposome Research 8 (1998) 283.
Ž. Pavelić, N. Škalko, I. Jalšenjak, Liposomes for vaginal drug delivery, J. Liposome Res. 8 (1998) 94.
Z. Knežević, D. Gosak, M. Hraste, I. Jalšenjak, Fluid-bed microencapsulation of ascorbic acid, J. Microencapsulation 15 (1998) 237.
Ž. Pavelić, N. Škalko-Basnet, I.Jalšenjak, Liposomes containing drugs for treatment of vaginal infections, Europ. J. Pharm. Sci. 8 (1999) 345.
J. Filipović-Grčić, V. Crc, I. Jalšenjak, Albumin-loaded PLA and PLGA microspheres in vitro evaluation, Boll. Chim. Farm.138 (1999) 14.
J. Filipović-Grčić, N. Škalko-Basnet, Ž. Pavelić, I. Čepelak, I. Jalšenjak, Mucoadhesive chitosan-coated liposomes: the influence of chitosan type on liposomal characteristics, The 18th Pharmaceutical Technology Conference Book, Volume 1 (1999) 280.
J. Filipović-Grčić, D. Voinovich, M. Moneghini, M. Bećirević-Laćan, L. Magarotto, I. Jalšenjak, Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-b-cyclodextrin inclusion complex, Europ. J. Pharm. Sci. 9 (2000) 373.
J. Filipović-Grčić, N. Škalko-Basnet, I. Jalšenjak, Mucoadhesive chitosan-coated liposomes: characteristics and stability, J. Microencapsulation 18 (2001) 3.
A. Martinac, J. Filipović-Grčić, M. Barbarić, B. Zorc, D. Voinovich, I. Jalšenjak, Gemfibrozil encapsulation and release from microspheres and macromolecular conjugates, Europ. J. Pharm. Sci. 17 (2002) 207.
J. Filipović-Grčić, B. Perissutti, M. Moneghini, D. Voinovich, A. Martinac, I. Jalšenjak, Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation, J. Pharm. Pharmacol. 55 (2003) 921.
Ž. Pavelić, N. Škalko-Basnet, R. Schubert, I. Jalšenjak, Liposomal gels for vaginal drug delivery, Chapter In: N. Duzgenes (Ed.) Liposomes,
I. Pepić, N. Jalšenjak, I. Jalšenjak, Micellar solutions of triblock copolymer surfactants with pilocarpine, Int. J. Pharm. 272 (2004) 57.
Other papers:
I. Štivić, I. Jalšenjak, Izotoniziranje hipotoničkih otopina pomoću nomograma, Acta Pharm. Jugosl. 18 (1968) 91
I. Štivić, I. Jalšenjak, O stabilnosti nekih parenteralnih otopina, Acta Pharm. Jugosl. 20 (1970) 57.
I. Štivić, I. Jalšenjak, Granulometrijska analiza disperznih sistema, Farm. Glas. 26 (1970) 471.
V. Petričić, I. Jalšenjak, Kompatibilnost kloralhidrata s lipofilnim podlogama, Acta Pharm. Jugosl. 21 (1971) 175.
I. Štivić, I. Jalšenjak, Reologija emolijentnih krema, Acta Pharm. Jugosl. 22 (1972) 119.
I. Jalšenjak, V. Petričić, Utjecaj podloga na granulometrijski sastav masti suspenzija s bornom kiselinom, Acta Pharm. Jugosl. 23 (1973) 119.
M. Čajkovac, I. Jalšenjak, Utjecaj prirodnih i sintetskih estera fosforne kiseline na svojstva pripravaka u dermatološkoj kozmetici, Acta Pharm. Jugosl. 25 (1975) 287.
I. Jalšenjak, Mikrokapsuliranje lijekova, Farm. Glas. 34 (1978) 407.
I. Jalšenjak, R. Senjković, Ispitivanje oslobađanja lijeka iz peroralnih pripravaka: I dio: Teorija i vrednovanje rezultata, Farm. Glas. 35 (1979) 107.
R. Senjković, I. Jalšenjak,, Ispitivanje oslobađanja lijeka iz peroralnih pripravaka: II dio: Metode ispitivanja in vitro, Farm. Glas. 35 (1979) 115.
R. Senjković, I. Jalšenjak, Svrha i postupak procjenjivanja inaktivacije izoniazida u organizmu, Farm. Glas. 36 (1980) 79.
V. Baričević, M. Četković-Cvrlje, I. Mišur, I. Jalšenjak, M. Slijepčević, Mikroenkapsulacija Langerhansovih otočića pankreasa i produkcija inzulina in vitro. Diab. Croat. 19 (1990) A57.